DrugPatentWatch Database Preview
Bionpharma Inc Company Profile
Email this page to a colleague
» See Plans and PricingWhat is the competitive landscape for BIONPHARMA INC, and what generic alternatives to BIONPHARMA INC drugs are available?
BIONPHARMA INC has forty-two approved drugs.
There are four US patents protecting BIONPHARMA INC drugs.
There are ten patent family members on BIONPHARMA INC drugs in thirteen countries and fifty-one supplementary protection certificates in thirteen countries.
Summary for Bionpharma Inc
| International Patents: | 10 |
| US Patents: | 4 |
| Tradenames: | 40 |
| Ingredients: | 36 |
| NDAs: | 42 |
| Drug Master File Entries: | 2 |
| Patent Litigation for Bionpharma Inc: | See patent lawsuits for Bionpharma Inc |
Drugs and US Patents for Bionpharma Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bionpharma Inc | AMANTADINE HYDROCHLORIDE | amantadine hydrochloride | CAPSULE;ORAL | 078720-001 | May 29, 2008 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Bionpharma Inc | NIMODIPINE | nimodipine | CAPSULE;ORAL | 076740-001 | Jan 17, 2008 | AB | RX | No | Yes | Start Trial | Start Trial | ||||
| Bionpharma Inc | AMPHETAMINE SULFATE | amphetamine sulfate | TABLET;ORAL | 212919-001 | Nov 22, 2019 | AA | RX | No | No | Start Trial | Start Trial | ||||
| Bionpharma Inc | LOPERAMIDE HYDROCHLORIDE | loperamide hydrochloride | CAPSULE;ORAL | 021855-002 | Aug 4, 2005 | OTC | Yes | Yes | Start Trial | Start Trial | |||||
| Bionpharma Inc | PARICALCITOL | paricalcitol | CAPSULE;ORAL | 202539-002 | Mar 27, 2014 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Bionpharma Inc | NAPROXEN SODIUM | naproxen sodium | CAPSULE;ORAL | 021920-001 | Feb 17, 2006 | OTC | Yes | Yes | 9,693,979 | Start Trial | Y | Start Trial | |||
| Bionpharma Inc | CLOBAZAM | clobazam | TABLET;ORAL | 208825-001 | Oct 22, 2018 | AB | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Bionpharma Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Bionpharma Inc | MIDOL LIQUID GELS | ibuprofen | CAPSULE;ORAL | 021472-001 | Oct 18, 2002 | 6,251,426 | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Bionpharma Inc Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| China | 102940887 | Start Trial |
| World Intellectual Property Organization (WIPO) | 2006096580 | Start Trial |
| European Patent Office | 1863458 | Start Trial |
| Mexico | 2007011039 | Start Trial |
| Spain | 2606767 | Start Trial |
| Canada | 2600023 | Start Trial |
| European Patent Office | 3061447 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Bionpharma Inc Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0984957 | PA2011005 | Lithuania | Start Trial | PRODUCT NAME: NAPROXENUM + ESOMEPRAZOLUM; REGISTRATION NO/DATE: LT/1/10/2302/001-LT/1/10/2302/012 20110126 |
| 1427415 | SPC/GB11/042 | United Kingdom | Start Trial | PRODUCT NAME: APIXABAN AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF; REGISTERED: UK EU/1/11/691/001 20110520; UK EU/1/11/691/002 20110520; UK EU/1/11/691/003 20110520; UK EU/1/11/691/004 20110520; UK EU/1/11/691/005 20110520 |
| 1411900 | SPC/GB11/015 | United Kingdom | Start Trial | PRODUCT NAME: NAPROXEN AND ESOMEPRAZOLE; REGISTERED: UK PL 17901/0263-0001 20101105 |
| 0387077 | SPC/GB04/003 | United Kingdom | Start Trial | PRODUCT NAME: PARICALCITOL; REGISTERED: ES SPAIN 64.974 20020809; UK PL 00037/0403 20030721 |
| 1427415 | 11C0042 | France | Start Trial | PRODUCT NAME: APIXABAN, EVENTUELLEMENT SOUS LA FORME D'UN DE SES SELS PHARMACEUTIQUEMENT ACCEPTABLES; REGISTRATION NO/DATE: EU/1/11/691/001 20110518 |
| 1427415 | PA2011012 | Lithuania | Start Trial | PRODUCT NAME: APIXABANUM; REGISTRATION NO/DATE: EU/1/11/691/001 - EU/1/11/691/005 20110518 |
| 0245997 | C300002 | Netherlands | Start Trial | PRODUCT NAME: DOFETILIDE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT; REGISTRATION NO/DATE: EU/1/99/121/001 - EU/1/99/121/015 19991129 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
